Loading...

Global Cord Blood Corporation

CO•NYSE
HealthcareMedical - Diagnostics & Research
$2.99
$0.00(0.00%)

Global Cord Blood Corporation (CO) Stock Overview

Explore Global Cord Blood Corporation’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for COStats details for CO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for COAnalyst Recommendations details for CO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

CEO

Ms. Ting Zheng

Employees

1,202

Headquarters

Bank of China Tower, Central

Founded

2007

Frequently Asked Questions